Home » Posts tagged with » nonvalvular atrial fibrillation
Micro Labs, Mylan secure FDA approval for first generics of Eliquis

Micro Labs, Mylan secure FDA approval for first generics of Eliquis

Micro Labs and Mylan Pharmaceuticals have secured approval from the US Food and Drug Administration (FDA) for two applications for the first generics of Eliquis (apixaban) tablets to cut down the risk of stroke and systemic embolism in patients having nonvalvular atrial fibrillation. Apixaban is also indicated for the preventive treatment of deep vein thrombosis […]